Investors looking for stocks in the Technology Services sector might want to consider either Smiths Group PLC (SMGZY) or Cellebrite DI Ltd. (CLBT). But which of these two companies is the best option ...

Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report) has received an average recommendation of “Buy” from the eight research ...

Cellebrite DI (NASDAQ:CLBT – Get Free Report) last posted its quarterly earnings data on Thursday, February 13th.The company reported $0.07 EPS for the quarter, missing analysts’ consensus ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

CLBT's ambitious financial targets include 24% CAGR in ARR and 20% CAGR in total revenues by 2028, with significant margin improvements since 2022. Despite a potential short-term sell-off ...

In this article, we are going to take a look at where Cellebrite DI Ltd. (NASDAQ:CLBT) stands against the other AI stocks. The evolving space of AI has been a major focus these days, as experts ...

In my opinion, Cellebrite DI (NASDAQ:CLBT) is the most promising play in the digital forensics space. The company offers the opportunity for extremely high barriers to entry and switching costs in ...

Investors looking for stocks in the Technology Services sector might want to consider either Smiths Group PLC (SMGZY) or Cellebrite DI Ltd. (CLBT). But which of these two companies is the best ...